Top Story

Knowledge of individual risk did not increase colorectal cancer screening adherence

October 20, 2014

Receipt of individualized genetic and environmental risk assessments did not increase colorectal cancer screening rates, even among study participants whose assessments showed they were at elevated risk for the disease, according to results of a randomized, controlled trial.

David S. Weinberg, MD, MSc, director of gastroenterology at Fox Chase Cancer Center in Philadelphia, and colleagues sought to evaluate whether a genetic and environmental risk assessment would improve screening adherence in 783 adults who were considered at average risk for colorectal cancer but were not regularly undergoing screening at baseline.

FDA News

FDA grants fast track designation to TAS-102 for mCRC

October 20, 2014
The FDA granted fast track designation to an investigational drug combination as a potential treatment for patients with refractory metastatic colorectal cancer, the…
Worth Building

Follow a checklist to help decide what to do with estate life insurance

October 20, 2014
Before recent changes in estate laws, it was common for attorneys, financial planners and insurance agents to recommend purchasing life insurance — commonly called…
In the Journals

Keratinocyte cancer imposes heavy burden on Dutch population

October 20, 2014
Researchers found keratinocyte cancer has become a large burden in Dutch society, and because incidence rates continue to rise, management has become even more…
More News Headlines »

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video

Nomogram predicted recurrence risk among women who underwent APBI

September 26, 2014
Jessica Wobb, MD, senior resident in radiation oncology at Beaumont Health System in Birmingham, Mich., describes how…
More »

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »